Display options
Cite
Alomari I, Seto A. Approach to Treatment of Bifurcation Lesions. Curr Treat Options Cardiovasc Med. 2016;18(1):5doi: 10.1007/s11936-015-0428-4.
Alomari, I., & Seto, A. (2016). Approach to Treatment of Bifurcation Lesions. Current treatment options in cardiovascular medicine, 18(1), 5. https://doi.org/10.1007/s11936-015-0428-4
Alomari, Ihab, and Seto, Arnold. "Approach to Treatment of Bifurcation Lesions." Current treatment options in cardiovascular medicine vol. 18,1 (2016): 5. doi: https://doi.org/10.1007/s11936-015-0428-4
Alomari I, Seto A. Approach to Treatment of Bifurcation Lesions. Curr Treat Options Cardiovasc Med. 2016 Jan;18(1):5. doi: 10.1007/s11936-015-0428-4. PMID: 26747627.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Cardiovasc Med. 2016 Jan;18(1):5. doi: 10.1007/s11936-015-0428-4.

Approach to Treatment of Bifurcation Lesions.

Current treatment options in cardiovascular medicine

Ihab Alomari, Arnold Seto

Affiliations

  1. University of California, Irvine, CA, USA. [email protected].
  2. University of California, Irvine, CA, USA. [email protected].

PMID: 26747627 DOI: 10.1007/s11936-015-0428-4

Abstract

OPINION STATEMENT: Bifurcation lesions are frequently encountered in the cath lab [1] and remain a challenge for conventional percutaneous coronary intervention (PCI) techniques. Although provisional stenting remains the default approach for most bifurcation lesions [2-6], the two-stent technique is more appropriate in certain situations. If a two-stent strategy is selected, then final kissing balloon inflation (KBI) should be performed. Adjunctive assessment with intravascular imaging (intravascular ultrasound (IVUS)/optical coherence tomography (OCT)) and physiologic testing (fractional flow reserve, FFR) should be performed liberally. Drug-eluting stents (DES) are typically utilized to reduce the risk of restenosis in bifurcation disease.

Keywords: Bifurcation; Coronary artery disease; Fractional flow reserve; Intravascular ultrasound; Percutaneous coronary intervention

References

  1. J Am Coll Cardiol. 2005 Aug 16;46(4):633-7 - PubMed
  2. EuroIntervention. 2012 Mar;7(11):1293-300 - PubMed
  3. Eur Heart J. 2008 Mar;29(6):726-32 - PubMed
  4. Rev Esp Cardiol. 2006 Feb;59(2):183 - PubMed
  5. J Am Coll Cardiol. 2015 Feb 17;65(6):533-43 - PubMed
  6. Int J Cardiol. 2013 Oct 9;168(4):3208-11 - PubMed
  7. JACC Cardiovasc Interv. 2012 Feb;5(2):155-61 - PubMed
  8. Catheter Cardiovasc Interv. 1999 Jun;47(2):258-64 - PubMed
  9. EuroIntervention. 2013 Jun 22;9(2):195-203 - PubMed
  10. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):205-11 - PubMed
  11. Rev Esp Cardiol (Engl Ed). 2014 Oct;67(10):804-12 - PubMed
  12. Am J Cardiol. 1997 Oct 15;80(8):994-7 - PubMed
  13. Eur Heart J. 2009 Sep;30(17):2087-94 - PubMed
  14. Cardiovasc Revasc Med. 2014 Apr;15(3):182-5 - PubMed
  15. Circulation. 2011 Dec 6;124(23):e574-651 - PubMed
  16. Am J Cardiol. 2003 Sep 15;92 (6):718-20 - PubMed
  17. JACC Cardiovasc Interv. 2009 Mar;2(3):185-94 - PubMed
  18. Circulation. 2009 Jan 6;119(1):71-8 - PubMed
  19. Catheter Cardiovasc Interv. 2011 May 1;77(6):798-806 - PubMed
  20. JACC Cardiovasc Interv. 2008 Jun;1(3):218-26 - PubMed
  21. Circulation. 2006 Oct 31;114(18):1955-61 - PubMed
  22. EuroIntervention. 2010 Dec;6 Suppl J:J65-71 - PubMed
  23. Circulation. 2011 Jan 4;123(1):79-86 - PubMed
  24. Catheter Cardiovasc Interv. 2011 Mar 1;77(4):537-45 - PubMed
  25. J Am Coll Cardiol. 2013 Apr 9;61(14 ):1482-8 - PubMed
  26. Circulation. 2010 Mar 16;121(10):1235-43 - PubMed
  27. JACC Cardiovasc Interv. 2012 Aug;5(8):803-11 - PubMed
  28. J Am Coll Cardiol. 2013 Jul 2;62(1):30-4 - PubMed
  29. J Am Coll Cardiol. 2011 Feb 22;57(8):914-20 - PubMed
  30. J Am Coll Cardiol. 2006 Feb 21;47(4):878-81 - PubMed
  31. Catheter Cardiovasc Interv. 2006 Jul;68(1):67-73 - PubMed
  32. Heart. 2007 Feb;93(2):249-50 - PubMed

Publication Types